Adverse Event Reporting

VAERS ID 1001432
Gender Female
Age
StateCode PA
Pharmaceutical Company MODERNA
Lot Number
Number of vaccinations 1
Vaccinated 2020-12-31
Onset 2021-01-02
Condition Life Threatening
Symptoms
  • Swollen tongue

Current Illness

Preexisting Conditions

Medical History/Concurrent Conditions: No adverse event (No reported medical history)

Other Medications

Previous Vaccinations

Allergies

Laboratory Data

Write-up

Swollen Tongue; A spontaneous report was received from a consumer concerning a 63-years-old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273), and who experienced swollen tongue.
The patient's medical history was not provided.
Concomitant product use was not provided by the reporter.
On 31 Dec 2020, approximately 3 days prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.
On 02 Jan 2021, patient experienced swollen tongue.
Treatment for the event included Benadryl.
Action taken with mRNA-1273 in response to the event was not provided.
The outcome of the event, swollen tongue was not reported.
; Reporter's Comments: This case concerns a 63-years old female patient with unknown medical history subject, who experienced a serious unexpected event of swollen tongue.
The event occurred three days after first dose of mRNA-1273 vaccine.
Treatment for the event included Benadryl.
; however, outcome wasn't reported.
The event was assessed as possibly related due to temporal association, however additional information has been requested.